The downregulation of CDC25C induces cell cycle arrest in G2/M phase in response to DNA damage via p53-mediated signal transduction, and its abnormal expression is associated with cancer initiation, development, metastasis, occurrence and poor prognosis. Here, CDC25C is linked to cancer.